凯普生物：披露累计诉讼、仲裁情况，涉金额4.16亿元

Core Points - The company, Capstone Bio, announced that as of the disclosure date, it and its subsidiaries have been involved in 102 litigation and arbitration cases over the past twelve months, with a total amount of 416 million yuan, accounting for 10.12% of the most recent audited net assets attributable to shareholders [1][1][1] - Among these cases, the company and its subsidiaries are plaintiffs in 69 cases, involving an amount of 357 million yuan, while they are defendants in 33 cases, involving an amount of 59 million yuan [1][1][1] - Currently, there are no significant litigation or arbitration matters where the amount involved exceeds 10% of the most recent audited net assets and is over 10 million yuan [1][1][1] - Some cases are still pending or unresolved, leading to uncertainty regarding their impact on the company's profits [1][1][1]